Angioimmunoblastic T-cell lymphoma with autoimmune hemolytic anemia and pure red cell aplasia.
- Author:
Fu-Xu WANG
1
;
Xue-Jun ZHANG
;
Ling PAN
;
Shu-Kai QIAO
;
Xiao-Ling GUO
;
Zuo-Ren DONG
Author Information
1. Department of Hematology, The Second Hospital of Hebei Medical University, Shijiazhuang, 050000, China. wangfx@hebmu.edu.cn
- Publication Type:Case Reports
- MeSH:
Adult;
Anemia, Hemolytic, Autoimmune;
complications;
diagnosis;
Humans;
Immunoblastic Lymphadenopathy;
complications;
diagnosis;
Lymphoma, T-Cell;
complications;
diagnosis;
Male;
Red-Cell Aplasia, Pure;
complications;
diagnosis
- From:
Journal of Experimental Hematology
2007;15(4):862-865
- CountryChina
- Language:Chinese
-
Abstract:
Angioimmunoblastic T-cell lymphoma (AILT) is a peripheral T-cell lymphoma often complicated autoimmune phenomena such as autoimmune cytopenia, and is a truly rare type of NHL. In order to investigate the clinical features, pathological manifestation of this lymphoma, and to explore its therapy protocol, a 37-years old patient with AILT was investigated. The routine blood examination, bone marrow smear, lymphonodus biopsy, Coombs test, flow cytometry for bone marrow mononuclear cells, serological test, immunochemistry method etc were performed for this patient. The results showed that the systemic lymphadenectasis and hepatosplenomegaly were seen in patient, the cervical lymphonode biopsy revealed AITL. The hematoglobin level and number of reticulocytes were very low. Coombs test was positive. Simultaneously, the bone marrow aspirate revealed erythroid aplasia. The warm type autoimmune hemolytic anemia (AIHA) and pure red cell aplasia (PRCA) were co-existed. After one course of chemotherapy with CHOP-E, infiltration sign of AITL patient with AIHA and PRCA disappeared. In conclusion, the AITL patient complicated with AIHA and PRCA was successfully diagnosed, the lymphonode biopsy and bone marrow smear showed more significant, the chemotherapy protocol of CHOP-E can give some effect to cure such angioimmunoblastic T cell lymphoma.
